Action Needed: Clozapine for Aggression
- The Angry Moms
- Oct 14
- 2 min read
Psychiatric providers, members, and supporters,
Below are two ways you can help expand the use of clozapine in critical populations, especially in incarcerated settings.
1) Sign & Share the Petition
Dr. Gill Honigfeld, aptly nicknamed “The Godfather of Clozapine,” has submitted a Citizen’s Petition to the FDA to grant a third official product label 'indication' for clozapine: "Reduction in the Risk of Recurrent Aggressive Behavior in Individuals with Serious Mental Illness.” Please support this vital and necessary change by submitting a comment!
=>TO SUBMIT A COMMENT, CLICK HERE:
Then copy and share the link!
Enter a simple statement of support, such as:
SMI conditions can cause aggressive behavior in otherwise peaceful individuals. Failing to treat these symptoms has led to tragic outcomes, criminal harm, and the mass incarceration of SMI individuals. Based on the evidence submitted, I strongly urge the FDA to add “Reduction in the Risk of Recurrent Aggressive Behavior in Individuals with Serious Mental Illness” as a third indication for clozapine.
(You can even copy and paste this!)
Psychiatrists and clinicians: Please make a short comment on how important clozapine has been in reducing aggressive behaviors in your patients!
TO READ THE FULL CITIZENS PETITION, CLICK HERE:
2) Support the Clinical Trial
The New York State Psychiatric Institute is recruiting patients for a nationwide clinical trial to study clozapine for the prevention of violence and aggression. This study is needed for FDA consideration to support this third treatment indication.
Do you know someone who is considering clozapine and is eligible to participate? The study is being conducted at multiple sites for another year. Individuals receive about $900 for their participation. And clozapine may transform their life!
TO LEARN MORE ABOUT THE CLINICAL TRIAL, CLICK HERE:
Thank you to our members and supporters!
The Angry Moms
